Study on the Protective Effect of a Flexible Sleeve Penis Protection Device on Penis After Circumcision

March 29, 2023 updated by: Liu Zhuo
Circumcision is a common clinical procedure for both circumcision and phimosis, which are common disorders of the male reproductive system. For post-circumcision patients, a flexible sleeve penile protection device was invented as a modification of the traditional gauze bandage. This study investigated the protective effect of the device by recruiting post-circumcision patients to use the device and collecting indicators related to post-operative recovery and patients' experience of using the device.

Study Overview

Detailed Description

Circumcision is a common clinical procedure for both circumcision and phimosis, which are common disorders of the male reproductive system. Post-circumcision patients remain at risk of gauze detachment, wound pain and post-operative bleeding, leading to serious post-operative adverse effects, including complications such as dehiscence and infection. The investigators have invented a flexible sleeve penile protection device, which consists of two components, a flexible sleeve and a hood, the main function of the flexible sleeve is to stop bleeding with compression and immobilisation, and the main function of the hood is to provide protection to the head of the penis and prevent the wound from rubbing against clothing leading to pain.

The aim of this study was to investigate the protective effect of a flexible sleeve penile protection device on post-circumcision patients in terms of gauze loosening and dislodging, post-operative pain and post-operative bleeding. This study was a prospective randomized controlled trial of patients who underwent circumcision at Peking University Third Hospital from February 2023 to May 2023. Patients in the experimental group were wrapped with this device postoperatively, while patients in the control group were wrapped with traditional gauze postoperatively. Patients were followed up regularly after surgery, and indicators such as complications, pain and recovery time were collected to investigate the protective effect of this device.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100191
        • Peking University Third Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 60 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  1. Diagnosed redundant prepuce and circumcised at Peking University Third Hospital.
  2. Male patients aged between 12 and 60 years (inclusive).
  3. The person or guardian fully understands and signs the informed consent form.

Exclusion Criteria:

  1. Acute urinary and genital infections, such as acute urethritis, acute prostatitis, acute epididymitis, etc., or trauma.
  2. Abnormal blood clotting function.
  3. Those who are allergic to the materials used in the manufacture of the product.
  4. Patients who are mentally incapable or unable to understand the requirements for participation in the study and have difficulty in cooperating.
  5. Subjects who, in the opinion of the investigator, are unable to comply with follow-up, compromising the scientific validity and integrity of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
Patients in the experimental group were wrapped with the Flexible Sleeve Penis Protection Device post-operatively.

Patients in the experimental group were wrapped with the Flexible Sleeve Penis Protection Device post-operatively.

Patients in the control group were wrapped with traditional gauze post-operatively.

Other: Control group
Patients in the control group were wrapped with traditional gauze after operation.

Patients in the experimental group were wrapped with the Flexible Sleeve Penis Protection Device post-operatively.

Patients in the control group were wrapped with traditional gauze post-operatively.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-operative complication
Time Frame: through study completion, an average of 12weeks
Assessing the incidence of post-operative complications
through study completion, an average of 12weeks
Foreskin edema score
Time Frame: through study completion, an average of 12weeks
Assessment of foreskin oedema which includes 0-6 points. A higher score means a more severe case of penile foreskin oedema
through study completion, an average of 12weeks
Healing time
Time Frame: through study completion, an average of 12weeks
Time for sutures to come off completely and time for wound healing
through study completion, an average of 12weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wound pain assessment
Time Frame: through study completion, an average of 12weeks
Using the Visual analogue scale ,which includes 0-10 points. A higher score means more pain
through study completion, an average of 12weeks
Comfort and convenience assessment
Time Frame: through study completion, an average of 12weeks
Comfort and convenience assessed by questionnaire
through study completion, an average of 12weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Zhuo Liu, MD, Peking University Third Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2023

Primary Completion (Anticipated)

June 30, 2023

Study Completion (Anticipated)

July 30, 2023

Study Registration Dates

First Submitted

February 9, 2023

First Submitted That Met QC Criteria

February 28, 2023

First Posted (Actual)

March 13, 2023

Study Record Updates

Last Update Posted (Actual)

March 31, 2023

Last Update Submitted That Met QC Criteria

March 29, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • M2022628

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Circumcision, Male

Clinical Trials on wrapped with the Flexible Sleeve Penis Protection Device

Subscribe